Antibodies

04 Dec 2008 MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor
04 Dec 2008 Symphogen and Meiji Seika Kaisha Ltd. Achieve Milestone in Discovery Collaboration for Recombinant Polyclonal Antibody, Sym006
03 Dec 2008 Conclusion of a joint research agreement between Chiome and Chugai: Innovation in the research and development of therapeutic antibodies by means of the revolutionary "ADLib(R) System" monoclonal antibody identification technology
03 Dec 2008 ProtAb, a Wholly Owned Subsidiary of Hadasit Bio Holdings, Receives U.S. Patent for Proximab for the Treatment of RA and Type-1 Diabetes
02 Dec 2008 Morphotek(R) Inc. Announces Initiation of Farletuzumab Phase II Study In Platinum-Resistant Ovarian Cancer
02 Dec 2008 Innate Pharma Announces The Entry Into Pre-clinical Validation of IPH 4201, a New Monoclonal Antibody Targeting Pancreatic Cancer
02 Dec 2008 UCB announces start of Phase I study for antibody drug candidate CDP6038
01 Dec 2008 FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review
01 Dec 2008 European Commission Approves Erbitux for First-Line Use in Head and Neck Cancer
28 Nov 2008 MedImmune Receives FDA Complete Response Letter on Motavizumab
26 Nov 2008 Arana commences ART621 Phase II rheumatoid arthritis trial
26 Nov 2008 MorphoSys and Galapagos enter alliance to co-develop novel therapeutic antibodies in bone & joint disease
26 Nov 2008 Amorfix Successfully Completes ALS Drug Discovery Program
24 Nov 2008 Medarex Announces Initiation of Phase 1b Clinical Development Program with MDX-1106 for the Treatment of Cancer
24 Nov 2008 Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
23 Nov 2008 Avastin Plus Commonly Used Chemotherapies Demonstrated Improved Progression-Free Survival In Advanced Breast Cancer
21 Nov 2008 CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
21 Nov 2008 RoActemra Receives Positive Opinion in Europe for the Treatment of Rheumatoid Arthritis
20 Nov 2008 Biovitrum and Symphogen Report Positive Clinical Results in Novel Rh- immunization Prevention Project
19 Nov 2008 Randomized Phase 2 Study of IMC-A12 for HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
18 Nov 2008 Genentech Issues Dear Healthcare Provider Letter Regarding a 2nd Case of PML in a Raptiva Patient
18 Nov 2008 Cimzia(R) studies show significant clinical benefits for mono- and combination therapy in patients with rheumatoid arthritis
17 Nov 2008 Life Science Pharmaceuticals Enters Into Agreement with Abbott to Develop Antibody 806
13 Nov 2008 Merck KGaA: Overall Survival in First-Line NSCLC Reaches 15 Months
13 Nov 2008 Antibody Shows Ability to Inhibit Disease in an Established RA Model

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top